Last updated on January 2019

Myrbetriq (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement

Brief description of study

The objective of this pilot study is to assess whether Myrbetriq will improve post-operative ureteral pain and discomfort, reduce bladder storage symptoms and increase quality of life following ureteral stenting.

Clinical Study Identifier: NCT02462837

Contact Investigators or Research Sites near you

Start Over

Danuta I Dynda, MD

SIUSOM - Division of Urology
Springfield, IL United States

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.